#United States #New Orleans #Baird Medical #microwave ablation #Thyroid Care

Baird Medical's Pioneering Role in Microwave Ablation Training

Baird Medical, recognized for its expertise in minimally invasive Microwave Ablation (MWA) technology, has taken significant steps in advancing thyroid care through its latest training program. Held in New Orleans, this session exemplified Baird’s commitment to enhancing clinical capabilities and improving patient care outcomes.

The training session, spearheaded by Dr. Emad Kandil from the Tulane University School of Medicine, featured hands-on training in MWA. This innovative treatment is gaining traction due to its ability to reduce recovery time and provide effective solutions for patients suffering from thyroid nodules.

Participating in the training were Dr. Ernest O. Asamoah and Dr. John W. Sistrunk, both seasoned endocrinologists. They observed live cases, engaged in critical discussions, and participated in practical sessions, mastering the state-of-the-art MWA equipment. Dr. Kandil, who has conducted over 80 MWA procedures, presented insights at the recent American Thyroid Association (ATA) annual meeting. He shared findings that underline the safety, efficacy, and innovative nature of MWA when compared to traditional Radiofrequency Ablation (RFA). He described MWA as a “novel, safe, and effective method” for treating select patients.

The post-training discussions were also crucial for participants, allowing for deeper exploration into MWA’s transformative potential. Both Dr. Asamoah and Dr. Sistrunk were awarded Certificates of Completion, signifying their readiness to integrate MWA into their practice—a significant advancement for their patients.

Haimei Wu, Chairwoman of Baird Medical, emphasized the importance of continued physician education in improving patient outcomes. According to her, “Investing in physician education is key to improving patient outcomes and expanding access to innovative treatments like MWA.” This commitment to education enables clinicians to broaden their treatment repertoire and improve community health.

Through targeted training initiatives, Baird Medical is facilitating the shift toward modern, minimally invasive therapies, connecting expert knowledge with advanced technology. These training programs not only support the adoption of MWA but also aim to foster greater access to effective, patient-centric solutions in thyroid care.

About Baird Medical

Baird Medical stands as a leading provider in the field of minimally invasive MWA technology. They deliver advanced treatment modalities for various conditions, including thyroid nodules, breast disorders, uterine fibroids, and liver cancer. As a publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing the quality of patient care through innovative medical devices characterized by precision and safety. For more information on their initiatives and technology, visit Baird Medical’s website.

By empowering healthcare providers with the necessary skills and knowledge, Baird Medical is set to influence the landscape of thyroid care positively, ensuring a brighter future for patients requiring medical intervention.